Evidence map›Paper›PMID 40199400›Full record

ArticleThe Journal of biological chemistry2025

The evolution of AKAPs and emergence of PKA isotype selective anchoring determinants.

Jerome I Falcone, Kristan H Cleveland, Mingu Kang, Brianna J Odle, Katherine A Forbush, John D Scott

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Regulation of Translation by PKA Signaling Pathway.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jerome I FalconeDepartment of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA.
Kristan H ClevelandDepartment of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA.
Mingu KangDepartment of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA.
Brianna J OdleDepartment of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA.
Katherine A ForbushDepartment of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA.
John D ScottDepartment of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA. Electronic address: scottjdw@uw.edu.

Funding

Diabetes, Obesity and Metabolism Training ProgramT32DK007247 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, KRISTINA Marie UTZSCHNEIDER · 1986 to 2026
$10.0M
Sodium and Calcium Channels: Structure, Function, Neuroplasticity, and DiseaseR35NS111573 · NINDS · UNIVERSITY OF WASHINGTON · PI SCOTT, JOHN D · 2019 to 2024
$6.1M
Defective PKA Signaling in Cushing's SyndromeR01DK119192 · NIDDK · UNIVERSITY OF WASHINGTON · PI John D Scott · 2018 to 2026
$4.4M
Targeting Oncogenic PKA signaling mechanismsR01CA279997 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI John D Gordan, John D Scott · 2024 to 2026
$1.9M
Biased AKAP signaling mechanismsR01DK141129 · NIDDK · UNIVERSITY OF WASHINGTON · PI John D Scott · 2024 to 2026
$1.7M
NCI NIH HHS R01 CA279997NIDDK NIH HHS R01 DK119192NIDDK NIH HHS R01 DK141129NIDDK NIH HHS T32 DK007247NINDS NIH HHS R35 NS111573
6 · The paper itself

Abstract

Cyclic AMP is a versatile signaling molecule utilized throughout the eukaryotic domain. A frequent use is to activate protein kinase A (PKA), a serine/threonine kinase that drives many physiological responses. Spatiotemporal organization of PKA occurs though association with A-kinase anchoring proteins (AKAPs). Sequence alignments and phylogenetic analyses trace the evolution of PKA regulatory (R) and catalytic (C) subunits and AKAPs from the emergence of metazoans. AKAPs that preferentially associate with the type I (RI) or type II (RII) regulatory subunits diverged at the advent of the vertebrate clade. Type I PKA anchoring proteins including smAKAP contain an FA motif at positions 1 and 2 of their amphipathic binding helices. Fluorescence recovery after photobleaching measurements indicate smAKAP preferentially associates with RI (T 1/2. 4.37 ± 1.2 s; n = 3) as compared to RII (T 1/2. 2.19 ± 0.5 s; n = 3). Parallel studies measured AKAP79 recovery half times of 8.74 ± 0.3 s (n = 3) for RI and 14.42 ± 2.1 s (n = 3) and for RII, respectively. Introduction of FA and AF motifs at either ends of the AKAP79 helix biases the full-length anchoring protein toward type I PKA signaling to reduce corticosterone release from adrenal cells by 61.5 ± 0.8% (n = 3). Conversely, substitution of the YA motif at the beginning of the smAKAP helix for a pair of leucine's abrogates RI anchoring. Thus, AKAPs have evolved from the base of the metazoan clade into specialized type I and type II PKA anchoring proteins.

Indexed as

A Kinase Anchor ProteinsCyclic AMP-Dependent Protein KinasesEvolution, MolecularAmino Acid MotifsAnimalsHumansPhylogenyA Kinase Anchor ProteinsCyclic AMP-Dependent Protein KinasesAKAPamphipathic helixevolutionprotein kinase Asignal transduction

Identifiers

PMID40199400
PMCPMC12083921

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.